Qiagen N.V. (QGEN)
After hours:
| Previous close | 42.02 |
| Open | 41.54 |
| Bid | 41.72 x 1000 |
| Ask | 42.77 x 800 |
| Day's range | 41.37 - 41.78 |
| 52-week range | 34.74 - 51.18 |
| Volume | |
| Avg. volume | 1,247,810 |
| Market cap | 9.531B |
| Beta (5Y monthly) | 0.43 |
| PE ratio (TTM) | 28.81 |
| EPS (TTM) | 1.45 |
| Earnings date | 05 Feb 2024 - 09 Feb 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 47.39 |
Simply Wall St.Estimating The Intrinsic Value Of Qiagen N.V. (NYSE:QGEN)
Key Insights The projected fair value for Qiagen is US$36.75 based on 2 Stage Free Cash Flow to Equity Current share...
ZacksWhy Is Seattle Genetics (SGEN) Down 0.7% Since Last Earnings Report?
Seattle Genetics (SGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
GlobeNewswireDNA Labs International solves significant cold cases with QIAGEN workflow for forensic genetic genealogy
QIAGEN’s ForenSeq Kintelligence System recently used by DNA Labs International in the U.S. to solve unidentified remains case in Oregon and 51-year-old criminal investigation in Georgia // ForenSeq Kintelligence enables identification of distant relatives in genealogy databases, helping to resolve previously unsolvable cases and bringing answers to victims and families // DNA Labs International is one of the first labs to offer this new approach to human identificationVenlo, the Netherlands, and
